Literature DB >> 10541506

Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: cohort study.

M Gabolde1, M Guilloud-Bataille, J Feingold, C Besmond.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541506      PMCID: PMC28266          DOI: 10.1136/bmj.319.7218.1166

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Genotyping of the three major allelic variants of the human mannose-binding lectin gene by denaturing gradient gel electrophoresis.

Authors:  M Gabolde; S Muralitharan; C Besmond
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

2.  Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis.

Authors:  J Hull; A H Thomson
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

3.  Molecular basis of opsonic defect in immunodeficient children.

Authors:  M Sumiya; M Super; P Tabona; R J Levinsky; T Arai; M W Turner; J A Summerfield
Journal:  Lancet       Date:  1991-06-29       Impact factor: 79.321

4.  Mannose binding protein gene mutations associated with unusual and severe infections in adults.

Authors:  J A Summerfield; S Ryder; M Sumiya; M Thursz; A Gorchein; M A Monteil; M W Turner
Journal:  Lancet       Date:  1995-04-08       Impact factor: 79.321

5.  Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency.

Authors:  P Garred; H O Madsen; B Hofmann; A Svejgaard
Journal:  Lancet       Date:  1995-10-07       Impact factor: 79.321

  5 in total
  24 in total

1.  The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosis.

Authors:  M Gabolde; D Hubert; M Guilloud-Bataille; C Lenaerts; J Feingold; C Besmond
Journal:  J Med Genet       Date:  2001-05       Impact factor: 6.318

Review 2.  Cystic fibrosis modifier genes.

Authors:  Jane Davies; Eric Alton; Uta Griesenbach
Journal:  J R Soc Med       Date:  2005       Impact factor: 5.344

3.  Association between mannan-binding lectin and impaired lung function in cystic fibrosis may be age-dependent.

Authors:  M S Muhlebach; S L MacDonald; B Button; J J Hubbard; M L Turner; R C Boucher; D C Kilpatrick
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

4.  Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis.

Authors:  B Fevang; T E Mollnes; A M Holm; T Ueland; L Heggelund; J K Damås; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

5.  New modifier loci in cystic fibrosis.

Authors:  Heiko Witt
Journal:  Nat Genet       Date:  2011-06       Impact factor: 38.330

6.  The influence of genetics on cystic fibrosis phenotypes.

Authors:  Michael R Knowles; Mitchell Drumm
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

7.  Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin.

Authors:  Kenneth Ahrend Petersen; Finn Matthiesen; Teit Agger; Leif Kongerslev; Steffen Thiel; Karen Cornelissen; Mads Axelsen
Journal:  J Clin Immunol       Date:  2006-08-09       Impact factor: 8.317

8.  Elevation of hepatic sulphotransferase activities in mice with resistance to cystic fibrosis.

Authors:  Josie L Falany; Heather Greer; Timea Kovacs; Eric J Sorscher; Charles N Falany
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

9.  Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system.

Authors:  M Cedzynski; J Szemraj; A S Swierzko; L Bak-Romaniszyn; M Banasik; K Zeman; D C Kilpatrick
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 10.  Update on gene modifiers in cystic fibrosis.

Authors:  Joseph M Collaco; Garry R Cutting
Journal:  Curr Opin Pulm Med       Date:  2008-11       Impact factor: 3.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.